OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 11, 2015
The Biosimilars Forum, along with numerous House members, advocated for the use of unique J-codes for biosimilars in a recent letter to CMS.
August 10, 2015
The company’s Scotland-based facility has successfully completed a scheduled inspection by the UK’s MHRA; there were no critical or major observations noted.
August 07, 2015
Flexion will have a dedicated manufacturing suite at Patheon's Swindon, England facility for Flexion's osteoarthritis steroid drug product.
August 06, 2015
A study of root cause in stability samples suggests the need for tighter control of the sodium lauryl sulfate manufacturing processes.
August 05, 2015
US generics manufacturer Amneal acquires a former J&J plant in Ireland.
August 03, 2015
Aprecia Pharmaceutical’s SPRITAM levetiracetam gains FDA approval for the treatment of epilepsy.
August 02, 2015
Engineered containment performance testing is a more robust method for validating containment systems than worker-exposure measurement methods.
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology.
August 01, 2015
Currently, pharma has only scratched the surface of the potential value of repurposing drugs, says consultant Hermann Mucke. Contract service partners are playing a more prominent role, but could play an even larger one in these efforts.